Colditz, Graham A <br/><br/>
Decline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin.  [electronic resource] 

 -  Breast cancer research : BCR  2007 
 - 108 p.  digital 
<br/><br/> Publication Type: Comment; Editorial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr1736  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--epidemiology<br/>Drug Therapy, Combination<br/>Estrogen Replacement Therapy--adverse effects<br/>Estrogens--adverse effects<br/>Female<br/>Humans<br/>Progestins--adverse effects